Neurological Models for Evaluation of Drug Delivery Systems
D.S. Reddy. NanoBioMedicine Vol. 3: NanoTheranostics
[PDF]
Hormones Affecting Reproduction
D.S. Reddy, John E. Gadsby. Book Chapter 28 (Endocrine Pharmacology) Chapter 28; pp. 717–731
[PDF]
Treating Neurological Diseases through Epigenetic Inhibition
Victoria Golub, D.S. Reddy. Epigenetic Inhibitors and Their Use to Treat Human Diseases Chapter 18
[PDF]
Neurosteroid mitigation of developmental neurological dysfunction, long-term epileptic biomarkers, chronic neuroinflammation, and neurodegeneration in a pediatric rat model of organophosphate exposure
Sreevidhya Ramakrishnan , Tanveer Singh, Albert Chen, Xin Wu,Doodipala Samba Reddy*. Journal of Pharmacology and Experimental Therapeutics Vol. 392 pp. 103555 (2025)
[PDF]
[DOI]
Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions
D.S. Reddy, Victoria M. Golub, Sreevidya Ramakrishnan, Severn B. Churn, Lee A. Shapiro, Jaclyn Iannucci, Asla Pitkanen, Aristea S. Galanopoulou, Rama Maganti, Detlev Boison. Pharmacological Reviews Vol. 77 (2025) 100080
[PDF]
[DOI]
Sex Differences in Organophosphate Model of Benzodiazepine- Refractory Status Epilepticus and Neuronal Damage
Tanveer Singh, Sreevidhya Ramakrishnan, Xin Wu, and Doodipala Samba Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 313–324 (2024)
[PDF]
[DOI]
Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents
D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 260–267 (2024)
[PDF]
[DOI]
Special Section on Medical Countermeasures, From Bench to Battlefield: Translating Experimental Therapies for Effective Combat Against Chemical Threats-Editorial
D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 257–259 (2024)
[PDF]
[DOI]
Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic
D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 273–300 (2024)
[PDF]
[DOI]
Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations, and Electrographic Ictal Biomarkers
Sreevidhya Ramakrishnan, Tanveer Singh, and Doodipala Samba Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 386–398 (2024)
[PDF]
[DOI]
Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation
Doodipala Samba Reddy, Tanveer Singh, Sreevidhya Ramakrishnan, Madeline Huber,and Xin Wu. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 399–415 (2024)
[PDF]
[DOI]
A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-Term Epileptic Seizure Activity, Neurologic Dysfunction and Neurodegeneration
Tanveer Singh, Sreevidhya Ramakrishnan, Xin Wu, and Doodipala Samba Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 416–431 (2024)
[PDF]
[DOI]
Long-Term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic Neurosteroids
C.A. Neff, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 388 pp. 451–468 (2024)
[PDF]
[DOI]
Bridging the Valley of Death: Translating Emerging Neurosteroid Therapies from Bench to Bedside
D.S. Reddy. ASPET Annual Meeting 2023 Abstract ASPET 2023
[PDF]
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
D.S. Reddy, I. Mbilinyi, W.A. Estes. Psychopharmacology 2023
[PDF]
[DOI]
Pathophysiological basis and promise of experimental therapies for Gulf War Illness, a chronic neuropsychiatric syndrome in veterans
M. Kodali, T. Jankay, A.K. Shetty, D.S. Reddy. Psychopharmacology 2023
[PDF]
[DOI]
Neuroendocrine insights for neurosteroid therapy of postpartum depression
D.S. Reddy. Trends in Molecular Medicine 2023
[PDF]
[DOI]
Serving those who serve through military medicine research
Sunitha Konatham. Vital Record (Texas A&M Health Science Center) 2023-04-12 00:00:00
[PDF]
[DOI]
Advances in targeted therapy of organophosphate neurotoxicity and chemical warfare nerve agents
D.S. Reddy. Sensing of Deadly Toxic Chemical Warfare Agents, Nerve Agent Stimulants, and their Toxicological Aspects Chapter 20; doi: 10.1016/B978-0-323-90553-4.00026-3
[PDF]
[DOI]
Pharmacotherapy of Basal Ganglia Disorders: Parkinson Disease and Huntington Disease
D.S. Reddy, Juan R. Sanchez-Ramos. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 15; 2023 edition
[PDF]
Drug Therapy for the Management of Attention Deficit-Hyperactivity Disorder
D.S. Reddy. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 18; 2023 edition
[PDF]
Drug Therapy for Spasticity Disorders
D.S. Reddy. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 22; 2023 edition
[PDF]
Drug Therapy for Migraine Headache
D.S. Reddy. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 31; 2023 edition
[PDF]
Building evidence on therapeutic efficacy and innovative mechanisms of cannabinoids in neurological disorders
D.S. Reddy. Experimental Neurology 364 (2023)
[PDF]
[DOI]
Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy
Victoria Golub, Sreevidhya Ramakrishnan, D.S. Reddy. Experimental Neurology Vol. 360 (2023) p. 114294; doi: 10.1016/j.expneurol.2022.114294
[PDF]
[DOI]
Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures
D.S. Reddy, Robert H. Mbilinyi, Sreevidhya Ramakrishnan. Experimental Neurology Vol. 359 (2023) p. 114240
[PDF]
[DOI]
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
Ashna Talwar, Emily Estes, Rajender Aparasu, D.S. Reddy. Experimental Neurology Vol. 359 (2023) p. 114238; doi: 10.1016/j.expneurol.2022.114238
[PDF]
[DOI]
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
D.S. Reddy. Experimental Neurology Vol. 359 (2023) p. 114237; doi: 10.1016/j.expneurol.2022.114237
[PDF]
[DOI]
Therapeutic Basis of Generic Substitution of Antiseizure Medications
J. Elmer, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 381 pp. 188–196 (2022)
[PDF]
[DOI]
Neurosteroid replacement therapy for perimenstrual catamenial epilepsy: a review and prognosis
D.S. Reddy. Journal of Neuroendocrinology Volume 34 2022; doi: 10.1111/jne.13028
[PDF]
[DOI]
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions
Victor M. Golub, D.S. Reddy. Pharmacological Reviews Vol. 74 pp. 387–438 (2022)
[PDF]
[DOI]
Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, sensorimotor deficits, and neuropsychological co-morbidities
Victoria M. Golub, D.S. Reddy. Experimental Neurology Vol. 348 (2022) p. 113946; doi: 10.1016/j.expneurol.2021.113946
[PDF]
[DOI]
Prognosis of Epileptic Seizure Event Onsets Using Random Survival Forests
Kahkashan Afrin, Revanth Dusi, Yuhao Zhong, D.S. Reddy, Satish T.S. Bukkapatnam. IISE Transactions on Healthcare Systems Engineering doi: 10.1080/24725579.2022.2051645
[PDF]
[DOI]
Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders
D.S. Reddy, Hasara Nethma Abeygunaratne. International Journal of Molecular Sciences Vol. 23 (2022) p. 11734; doi: 10.3390/ijms231911734
[PDF]
[DOI]
Does Stress Trigger Seizures? Evidence from Experimental Models
D.S. Reddy, Wesley Thompson, Gianmarco Calderara. Current Topics in Behavioral Neurosciences pp. 41-64 Vol. 55, pp. 41–64; Published Online: 6 February 2021
[PDF]
[DOI]
Long-term changes in neuroimaging markers, cognitive function and psychiatric symptoms in an experimental model of Gulf War Illness
Xin Wu, Ashok K. Shetty,Doodipala Samba Reddy. Life Sciences Vol. 285 (2021)
[PDF]
[DOI]
Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman
Doodipala Samba Reddy * Marcus Zaayman, Ramkumar Kuruba, Xin Wu. Neuropharmacology Vol. 191 pp. 108571 (2021)
[PDF]
[DOI]
Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis
D.S. Reddy, H.K. Thompson, G. Calderara. Neuroscience Letters Vol. 750 (2021)
[PDF]
[DOI]
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Victoria Golub, D.S. Reddy. Cannabinoids and Neuropsychiatric Disorders (Advances in Experimental Medicine and Biology 1264) Chapter 7; doi: 10.1007/978-3-030-57369-0_7
[PDF]
[DOI]
Magnetic resonance imaging analysis of long-term neuropathology after exposure to the nerve agent soman: correlation with histopathology and neurological dysfunction
Sandesh D. Reddy, Xin Wu, Ramkumar Kuruba, Vidya Sridhar, D.S. Reddy. Annals of the New York Academy of Sciences Vol 148: pp. 116-135
[PDF]
[DOI]
Development of Biomarkers for Traumatic Brain Injury and Posttraumatic Epilepsy
D.S. Reddy, K. Bhatt. Pharmacological Reviews Vol. 72 pp. 719–766 (2020)
[PDF]
Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam
Shu-Hui Chuang, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 372 pp. 285–298 (2020)
[PDF]
[DOI]
Sex differences in the epilepsies and associated comorbidities: Implications for use and development of pharmacotherapies
Caitlin A. Christian, D.S. Reddy, Jamie Maguire, Patrick A. Forcelli. Pharmacological Reviews Vol. 72 pp. 767–800 (2020)
[PDF]
[DOI]
Brain structural and neuroendocrine basis of sex differences in epilepsy
D.S. Reddy. Handbook of Clinical Neurology Vol. 175 (Sex Differences in Neurology and Psychiatry) Chapter 14; doi: 10.1016/B978-0-444-64123-6.00016-3
[PDF]
[DOI]
Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury
D.S. Reddy, Dheepthi Perumal, Ramkumar Kuruba, Xin Wu, Victoria Golub, Andy Habib. Epilepsia Open Vol. 5 (2020) pp. 198–212; doi: 10.1002/epi4.12389
[PDF]
[DOI]
Neurosteroids: Biosynthesis, Molecular Mechanisms, and Neurophysiological Functions in the Human Brain
D.S. Reddy, Kushal Bakshi. Hormonal Signaling in Biology and Medicine Chapter 4 pp. 69+; doi: 10.1016/B978-0-12-813814-4.00004-3
[PDF]
[DOI]
Clinical Pharmacology and Therapeutics of Antiepileptic Drugs for Treatment of Epilepsy and Seizure Disorders
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 13 Issue 6 (Nov-Dec 2020); doi: 10.37285/ijpsn.2020.13.6.1 pp. 5165-5180
[PDF]
[DOI]
Catamenial Epilepsy: A Review of Hormonal and Neurosteroid Mechanism and New Anticonvulsant Drug Development
D.S. Reddy. Book Chapter (Ovarian Cycle) In: Ovarian Cycle, Litwack G (Ed.); Vitamins and Hormones Vol. 107 (2018); Academic Press/Elsevier
[PDF]
Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus
Shu-Hui Chuang, D.S. Reddy. Neuropharmacology Vol. 148 pp. 244–256 (2019)
[PDF]
[DOI]
Mechanism-based novel antidotes for organophosphate neurotoxicity
D.S. Reddy. Current Opinion in Toxicology Vol. 14 (2019) pp. 35–45; doi: 10.1016/j.cotox.2019.08.001
[PDF]
[DOI]
An enigmatic role of tonic inhibition in gabapentin therapy
D.S. Reddy. EBioMedicine Vol. 42 (2019) pp. 14–15; doi: 10.1016/j.ebiom.2019.03.047
[PDF]
[DOI]
Extrasynaptic gamma-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures
D.S. Reddy, Chase Matthew Carver, Bryan Clossen, Xin Wu. Epilepsia Vol. 60 (2019) pp. 730–743; doi: 10.1111/epi.14693
[PDF]
[DOI]
Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy
Sandesh D. Reddy, Iyan Younus, Vidya Sridhar, D.S. Reddy. International Journal of Molecular Sciences Vol. 20 (2019) p. 220; doi: 10.3390/ijms20010220
[PDF]
[DOI]
Epigenetic Histone Deacetylation Inhibition Prevents the Development and Persistence of Temporal Lobe Epilepsy
Sandesh D. Reddy, Bryan L. Clossen, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 364 pp. 97–109 (2018)
[PDF]
[DOI]
Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents
Xin Wu, Ramkumar Kuruba, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 367 pp. 302–321 (2018)
[PDF]
[DOI]
Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy
Shu-Hui Chuang, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 364 pp. 180–197 (2018)
[PDF]
[DOI]
3b-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic d-Subunit g-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield
Shu-Hui Chuang, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 365 pp. 583–601 (2018)
[PDF]
[DOI]
Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication
Ramkumar Kuruba, Xin Wu, D.S. Reddy. Biochimica et Biophysica Acta - Molecular Basis of Disease Vol. 1864 (2018) pp. 2845–2858
[PDF]
[DOI]
Drug Therapy for the Management of Attention Deficit-Hyperactivity Disorder
D.S. Reddy. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 18; ISBN 978-0-323-47652-2; 2018 edition
[PDF]
Drug Therapy for Migraine Headache
D.S. Reddy. Brody's Human Pharmacology: Mechanism-Based Therapeutics Chapter 31; 2018 edition
[PDF]
A resurging boom in new drugs for epilepsy and brain disorders
Iyan Younus, D.S. Reddy. Expert Review of Clinical Pharmacology Vol. 11 No. 1 (2018) pp. 27–45; doi: 10.1080/17512433.2018.1386553
[PDF]
[DOI]
Role of beta2/3-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis
D.S. Reddy, Ryan F. Yoshimura, Gunasekaran Ramanathan, Chase Carver, Timothy B. Johnstone, Derk J. Hogenkamp, Kelvin W. Gee. Epilepsy and Behavior Vol. 82 (2018) pp. 57–63; doi: 10.1016/j.yebeh.2018.02.020
[PDF]
[DOI]
Thinking Above the Genome: Epigenetic Manipulation as a Disease-Modifying Strategy in Epilepsy
D.S. Reddy. Epilepsy Currents Vol. 18 No. 4 (Jul/Aug 2018) pp. 255–256
[PDF]
[DOI]
Neuroendocrine aspects of improving sleep in epilepsy
D.S. Reddy, Shu-Hui Chuang, Dayton Hunn, Amy Z. Crepeau, Rama Maganti. Epilepsy Research Vol. 147 (2018) pp. 32–41
[PDF]
[DOI]
GABA-A Receptors Mediate Tonic Inhibition and Neurosteroid Sensitivity in the Brain
D.S. Reddy. Vitamins and Hormones (Hormonal Signaling in Biology and Medicine) Vol. 107 pp. 177–199 (2018); doi: 10.1016/bs.vh.2017.12.001
[PDF]
[DOI]
Clinical Overview of Innovative New Drug Approvals in 2017
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 11 Issue 5 (Sep-Oct 2018) pp. 4225-4230
[PDF]
[DOI]
Pharmaceutical and Biotechnological Applications of Transgenic Technology
Tina Reddy, D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 11 Issue 4 (Jul-Aug 2018) pp. 4145-4153
[PDF]
[DOI]
Is Prenatal Valproate Exposure a Risk Factor for Autism?
D.S. Reddy, Jonathan Brewer, Maunica Manchi. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 11 Issue 2 (Mar-Apr 2018) pp. 4007-4011
[PDF]
[DOI]
United States Patent Application
Doodipala, Samba Reddy.
[PDF]
Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy
Bryan L. Clossen, D.S. Reddy. Biochimica et Biophysica Acta Vol. 1863 (2017) pp. 1519–1538; Received 22 Nov 2016; Available online 05 Feb 2017
[PDF]
[DOI]
PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields
D.S. Reddy, Omkaram Gangisetty, Xin Wu. Brain Research Vol. 1659 (2017) pp. 142–147; Received 23 Oct 2016; Available online 28 Jan 2017
[PDF]
[DOI]
Catamenial Epilepsy Pathophysiology and Current Treatment
D.S. Reddy. Current Treatment Options in Neurology Vol. 19 pp. 1–16 (2017)
[PDF]
Catamenial-Like Seizure Exacerbation in Mice with Targeted Ablation of Extrasynaptic dGABA-A Receptors in the Brain
D.S. Reddy, B.L. Clossen. Journal of Neuroscience Research Vol. 95 pp. 1906–1916 (2017)
[PDF]
Prospects of Modeling Poststroke Epileptogenesis
Doodipala Samba Reddy,* Aamir Bhimani, Ramkumar Kuruba,Min Jung Park, and Farida Sohrabji. Journal of Neuroscience Research Vol. 95 pp. 1000–1016 (2017)
[PDF]
[DOI]
Epigenetic mechanisms of neurosteroid regulation of pharmacoresistant epilepsy
Iyan Younus, D.S. Reddy. Pharmacology & Therapeutics Vol. 177 pp. 108–122 (2017)
[PDF]
Sex differences in seizure expression and response to neurosteroid treatment in catamenial epilepsy models
D.S. Reddy. Pharmacology Biochemistry and Behavior Vol. 152 pp. 97–104 (2017)
[PDF]
Neurocysticercosis as an infectious acquired epilepsy worldwide
D.S. Reddy, Randy Volkmer II. Seizure Vol. 52 pp. 176–181 (2017)
[PDF]
[DOI]
The Utility of Cannabidiol in the Treatment of Refractory Epilepsy
D.S. Reddy. Clinical Pharmacology and Therapeutics Vol. 101 No. 2 (Feb 2017); doi: 10.1002/cpt.441
[PDF]
[DOI]
A Comparative Toxidrome Analysis of Human Organophosphate and Nerve Agent Poisonings Using Social Media
D.S. Reddy, E. Colman. Clinical and Translational Science Vol. 10 no 3 (2017) pp. 225–230; doi: 10.1111/cts.12435
[PDF]
[DOI]
Perimenstrual Seizures and Neurosteroid Withdrawal
D.S. Reddy. Models of Seizures and Epilepsy (Pitkanen et al., eds.) Chapter 62 pp. 933+; doi: 10.1016/B978-0-12-804066-9.00063-8
[PDF]
[DOI]
Do oral contraceptives increase epileptic seizures?
D.S. Reddy. Expert Review of Neurotherapeutics Vol. 17 No. 2 (2017) pp. 129–134; doi: 10.1080/14737175.2016.1243472
[PDF]
[DOI]
Atomic force microscopy investigations of fibronectin and alpha5beta1-integrin signaling in neuroplasticity and seizure susceptibility in experimental epilepsy
Xin Wu, Mariappan Muthuchamy, D.S. Reddy. Epilepsy Research Vol. 138 (2017) pp. 71–80
[PDF]
[DOI]
Novel Drugs and Biologics of 2016: A Boom for Neurodrugs in the Pipeline
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 10 Issue 5 (Sep-Oct 2017) pp. 3809-3814
[PDF]
[DOI]
Clinical Pharmacology of Modern Antiepileptic Drugs
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 10 Issue 6 (Nov-Dec 2017) pp. 3875-3890
[PDF]
[DOI]
Sex Differences in the Anticonvulsant Activity of Neurosteroids
D.S. Reddy. Journal of Neuroscience Research Vol. 95 (2017) pp. 661–670; doi: 10.1002/jnr.23853 pp. 661-670
[PDF]
[DOI]
Drug Therapy for Migraine Headache (Chapter 31)
D.S. Reddy. Brody's Human Pharmacology (Wecker, ed.), Elsevier Section 5 ISBN: 978-0-323-47652-2
[PDF]
Perimenstrual Seizures and Neurosteroid Withdrawal
D.S. Reddy. Models of Seizures and Epilepsy (Pitkanen et al., eds.), Elsevier Chapter 62 pp. 933–940 ; http://dx.doi.org/10.1016/B978-0-12-804066-9.00063-8
[PDF]
[DOI]
Neurosteroids for the potential protection of humans against organophosphate toxicity
D.S. Reddy. Annals of the New York Academy of Sciences Vol. 1378 (2016) pp. 25–32; doi: 10.1111/nyas.13160
[PDF]
[DOI]
Commentary: Neurosteroid Replacement Therapy for Perimenstrual Catamenial Epilepsy
D.S. Reddy. Epilepsy Currents Vol. 16(2) pp. 99–101 (2016)
[PDF]
Catamenial epilepsy: Discovery of an extrasynaptic molecular mechanism for targeted therapy
D.S. Reddy. Frontiers in Cellular Neuroscience Sec. Cellular Neurophysiology
Volume 10
[PDF]
[DOI]
Catamenial Epilepsy: Research Update
D.S. Reddy. Epilepsy Currents Vol. 16(5) (2016)
[PDF]
Neurosteroids as broad-spectrum anticonvulsants and their role in the treatment of epilepsy
D.S. Reddy, V.M. Golub. Pharmacological Reviews Vol. 68(2) pp. 247–265 (2016)
[PDF]
The Pharmacological Basis of Cannabis Therapy for Epilepsy
D.S. Reddy, V.M. Golub. Journal of Pharmacology and Experimental Therapeutics Vol. 357 pp. 45–55 (2016)
[PDF]
[DOI]
Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic dGABAA Receptors
Chase Matthew Carver and Doodipala Samba Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 357 pp. 188–204 (2016)
[PDF]
[DOI]
Zinc Selectively Blocks Neurosteroid-Sensitive Extrasynaptic GABAA Receptors in the Hippocampus
Caitlin M. Carver, Shu-Hui Chuang, D.S. Reddy. The Journal of Neuroscience Vol. 36(31) pp. 8070–8077 (2016)
[PDF]
[DOI]
Resurgence of Cannabinoid Phytopharmaceuticals in USA
D.S. Reddy. Pharma Times Vol. 48 - No. 03
[PDF]
Clinical Potential of Neurosteroids for CNS Disorders
D.S. Reddy, William A. Estes. Trends in Pharmacological Sciences Vol. 37(7) pp. 543–561 (2016); doi: 10.1016/j.tips.2016.04.003
[PDF]
[DOI]
Sex Differences in Neurological Diseases
Farida Sohrabji, C. Jane Welsh, D.S. Reddy. Book Chapter 12 (Sex Differences in the Central Nervous System) Chapter 12 in: Sex Differences in the Central Nervous System; Elsevier, 2016; doi: 10.1016/B978-0-12-802114-9.00012-3
[PDF]
[DOI]
Potentiating the Strength of Extrasynaptic Currents by Neurosteroid Hormones
D.S. Reddy, C.M. Carver. Epilepsy Currents Vol. 16 No. 4 (Jul/Aug 2016) pp. 261–262
[PDF]
[DOI]
Seizure facilitating activity of the oral contraceptive ethinyl estradiol
Iyan Younus, D.S. Reddy. Epilepsy Research Vol. 121 (2016) pp. 29–32
[PDF]
[DOI]
Atomic Force Microscopy Protocol for Measurement of Membrane Plasticity and Extracellular Interactions in Single Neurons in Epilepsy
Xin Wu, Mariappan Muthuchamy, D.S. Reddy. Frontiers in Aging Neuroscience Vol. 8 p. 88 (2016); doi: 10.3389/fnagi.2016.00088
[PDF]
[DOI]
Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy
D.S. Reddy. Frontiers in Cellular Neuroscience Vol. 10 p. 101 (2016); doi: 10.3389/fncel.2016.00101
[PDF]
[DOI]
The Novel Drugs of 2015 – An Extraordinary Growth of Innovative Pharmaceuticals
D.S. Reddy, Savitha Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 9 Issue 4 (Jul-Aug 2016) pp. 3331-3336
[PDF]
[DOI]
Cellular and Molecular Mechanisms of Neuroinflammation in Epilepsy
D.S. Reddy, Bryan Clossen, Harika Medi. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 9 Issue 4 (Jul-Aug 2016) pp. 3337-3344
[PDF]
New Neurosteroids May Target Refractory Epilepsy
D.S. Reddy. MedicalResearch.com 2016-02-21 00:00:00
[PDF]
[DOI]
Potentiating the Strength of Extrasynaptic Currents by Neurosteroid Hormones [Commentary on: Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic GABAA Receptors]
Carver CM, D.S. Reddy. Epilepsy Currents Vol. 16, No. 4 (July/August 2016), pp. 261–262
[PDF]
Neurosteroids as Novel Anticonvulsant Antidotes for Nerve Agent Seizures
Iyan Younus, D.S. Reddy. AAPS Annual Meeting 2015 Abstract AAPS 2015
[PDF]
Commentary on a new anti-seizure drug for refractory epilepsy
D.S. Reddy. Epilepsy Currents Vol. 15 (2015)
[PDF]
New-Onset Seizures in the Elderly: Etiology and Management in the Outpatient Setting
D.S. Reddy, A. Bhatt. Epilepsy Currents Vol. 15(3) (2015)
[PDF]
Oral Contraceptives and Epilepsy: Drug Interactions and Effects on Seizures
D.S. Reddy. Epilepsy Research Vol. 116 pp. 35–46 (2015)
[PDF]
Antiseizure Activity of Midazolam in Mice Lacking d-Subunit Extrasynaptic GABAA Receptors
Sandesh Reddy, Iyan Younus, Bryan L. Clossen, D.S. Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 353 pp. 517–528 (2015)
[PDF]
[DOI]
Seeking Ways to Treat Epilepsy
Texas A&M Today. Texas A&M Today 2015-10-28 00:00:00
[PDF]
[DOI]
The Perimenstrual Delta Force: A Trojan Horse for Neurosteroid Effects
D.S. Reddy, C.M. Carver, C. Wu, O. Gangisetty. Epilepsy Currents Vol. 15 No. 3 (May/June 2015) pp. 153
[PDF]
[DOI]
Midazolam as an anticonvulsant antidote for organophosphate intoxication—A pharmacotherapeutic appraisal
Sandesh D. Reddy, D.S. Reddy. Epilepsia Vol. 56(6) pp. 813–821 (2015); doi: 10.1111/epi.12989
[PDF]
[DOI]
Explorations
. Explorations: The Texas A&M Undergraduate Journal Fall 2015 Vol. 7
[PDF]
Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration
Victoria M. Golub, Jonathan Brewer, Xin Wu, Ramkumar Kuruba, Jenessa Short, Maunica Manchi, Megan Swonke, Iyan Younus, D.S. Reddy. Frontiers in Aging Neuroscience Vol. 7 p. 196 (2015); doi: 10.3389/fnagi.2015.00196
[PDF]
[DOI]
The Novel Drugs of 2014 – Record Approvals for Niche Markets
Savitha M. Reddy, D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 8 Issue 3 (Jul-Sep 2015) pp. 2889-2893
[PDF]
[DOI]
SGLT2 Inhibitors: A New Generation of Antidiabetic Drugs
Kuchana Madhavi, D.S. Reddy, S.K. Kulkarni. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 8 Issue 2 (Apr-Jun 2015) pp. 2787-2798
[PDF]
[DOI]
Current Landscape of Pharma Industry: From Discovery to Outsourcing Worldwide
D.S. Reddy. 66th Indian Pharmaceutical Congress Speaker's Abstracts January 2015 (66th IPC, Hyderabad)
[PDF]
Neurosteroid replacement therapy aims to control seizures in women
D.S. Reddy. Research at Texas A&M (research.tamu.edu) 2015-05-05 00:00:00
[PDF]
[DOI]
The Perimenstrual Delta Force: A Trojan Horse for Neurosteroid Effects
Carver CM, Wu C, Gangisetty O, D.S. Reddy. Epilepsy Currents Vol. 15, No. 2 (March/April 2015), pp. 80–82
[PDF]
[DOI]
Neurosteroid-sensitive delta-GABAA receptors as targets for treating epilepsy
D.S. Reddy. Epilepsia Vol. 55(9) pp. 1358–1368 (2014); doi: 10.1111/epi.12696
[DOI]
Protection against status epilepticus- and nerve-agent-induced seizures and brain injury by the neuroactive steroid allopregnanolone in mice
Iyan Younus, D.S. Reddy. Epilepsy & Behavior Vol. 41 pp. 145–157 (2014); doi: 10.1016/j.yebeh.2014.09.057
[PDF]
[DOI]
SFN 2014 Abstract: Neurosteroid therapies for refractory seizures
D.S. Reddy. Society for Neuroscience 2014 Abstract SFN Abstract 2014; UCI-50027
[PDF]
Neurosteroids and their role in sex-specific epilepsies
D.S. Reddy. Neurobiology of Disease Vol. 72 pp. 198–209 (2014)
[PDF]
[DOI]
Perimenstrual-Like Hormonal Regulation of Extrasynaptic -Containing GABAA Receptors Mediating Tonic Inhibition and Neurosteroid Sensitivity
Chase Matthew Carver, Xin Wu, Omkaram Gangisetty, and Doodipala Samba Reddy. The Journal of Neuroscience Vol. 34(43) pp. 14181–14197 (2014)
[PDF]
[DOI]
An Overview of Novel Drugs and New Chemical Entities in 2013
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 7 Issue 3 (Jul-Sep 2014) pp. 2505-2508
[PDF]
[DOI]
Clinical Pharmacology of Current Antiepileptic Drugs
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 7 Issue 1 (Jan-Mar 2014) pp. 2305-2319
[PDF]
[DOI]
New drugs of 2013 – orphans and blockbusters
D.S. Reddy. Chronicle PharmaBiz 2014-11-27 00:00:00
[PDF]
Organophosphate nerve agent intoxication and neurosteroid anticonvulsant therapy
D.S. Reddy. CNS Spectrums Vol. 18 (2013)
[PDF]
Estrous Cycle Regulation of Extrasynaptic d-Containing GABAA Receptor-Mediated Tonic Inhibition and Limbic Epileptogenesis
Xin Wu, Omkaram Gangisetty, Chase Matthew Carver, and Doodipala Samba Reddy. Journal of Pharmacology and Experimental Therapeutics Vol. 346 pp. 146–160 (2013)
[PDF]
[DOI]
Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability
Caitlin M. Carver, D.S. Reddy. Psychopharmacology Vol. 230 pp. 151–188 (2013)
[PDF]
[DOI]
Novel New Drug Approvals in 2011: A Succinct Analysis of Drug Discovery Trends in the United States
D.S. Reddy. Pharma Times Vol. 45 No. 8 (2013)
[PDF]
[DOI]
Current Pharmacotherapy of Attention Deficit Hyperactivity Disorder
D.S. Reddy. Drugs of Today Vol. 49(10) pp. 647–665 (2013); doi: 10.1358/dot.2013.49.10.2008996
[PDF]
[DOI]
The pathophysiological and pharmacological basis of current drug treatment of migraine headache
D.S. Reddy. Expert Review of Clinical Pharmacology Vol. 6(3) pp. 271–288 (2013); doi: 10.1586/ECP.13.14
[PDF]
[DOI]
Neurosteroid Influences on Neuronal Excitability: The Menstrual Cycle and Catamenial Epilepsy as Dynamic Models
D.S. Reddy. Epilepsy in Women (Harden, Thomas, Tomson eds.) Chapter 3 pp. 23+; Wiley-Blackwell 2013
[PDF]
Role of hormones and neurosteroids in epileptogenesis
D.S. Reddy. Frontiers in Cellular Neuroscience Vol. 7 p. 115 (2013); doi: 10.3389/fncel.2013.00115
[PDF]
[DOI]
Neuroendocrine aspects of catamenial epilepsy
D.S. Reddy. Hormones and Behavior Vol. 63 (2013) pp. 254–266
[PDF]
[DOI]
Experimental Models of Status Epilepticus and Neuronal Injury for Evaluation of Therapeutic Interventions
D.S. Reddy, Ramkumar Kuruba. International Journal of Molecular Sciences Vol. 14 (2013) pp. 18284–18318; doi: 10.3390/ijms140918284
[PDF]
[DOI]
New Drugs of 2012: A Concise Overview of the NMEs and Trends for Innovative Brand Market in the United States
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 6 Issue 2 (Jul-Sep 2013) pp. 2009-2013
[PDF]
[DOI]
Neurosteroid-based pharmacotherapy for nerve agent intoxication
D.S. Reddy. Book Chapter (Chemical Warfare Agents) Chapter in: Chemical Warfare Agents: Pharmacology, Toxicology, and Therapeutics; 2012
[PDF]
A Mouse Kindling Model of Perimenstrual Catamenial Epilepsy
Doodipala Samba Reddy, Jordan Gould, and O. Gangisetty. Journal of Pharmacology and Experimental Therapeutics Vol. 341 pp. 784–793 (2012)
[PDF]
[DOI]
Integrins as receptor targets for neurological disorders
Xin Wu, D.S. Reddy. Pharmacology & Therapeutics Vol. 134 pp. 68–81 (2012)
[PDF]
[DOI]
Neurosteroids: Endogenous role in the human brain and therapeutic potentials
D.S. Reddy. Book Chapter (Jasper's Basic Mechanisms of the Epilepsies, 4th ed.) Chapter in: Jasper's Basic Mechanisms of the Epilepsies, 4th edition; 2012
[PDF]
Current Drug Shortages in the United States
D.S. Reddy. Pharma Times Vol. 44 - No. 06
[PDF]
[DOI]
Neuroscience & Experimental Therapeutics Department Update (July 2012)
D.S. Reddy. Dean's E-Newsletter (Texas A&M Health Science Center) 2012-07-01 00:00:00
[PDF]
Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis
D.S. Reddy, G. Ramanathan. Epilepsy and Behavior Vol. 25 (2012) pp. 92–97; doi: 10.1016/j.yebeh.2012.05.024
[PDF]
[DOI]
Novel New Drug Approvals in 2011: A Succinct Analysis of Drug Discovery Trends in the United States
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 5 Issue 2 (Jul-Sep 2012) pp. 1661-1665
[PDF]
[DOI]
Current drug shortages in United States
D.S. Reddy. PharmaBiz 2012-01-25 00:00:00
[PDF]
[DOI]
Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors
D.S. Reddy, Ashwin Mohan. The Journal of Neuroscience Vol. 31(2) pp. 650–658 (2011)
[PDF]
[DOI]
D. Samba Reddy Published in Journal of Neuroscience
D.S. Reddy. Dean's E-Newsletter, Texas A&M Health Science Center 2011-01-01 00:00:00
[PDF]
Neuroendocrinological aspects of epilepsy: Important issues and trends in future research
Alison M. Pack, D.S. Reddy, Susan Duncan, Andrew Herzog. Epilepsy and Behavior Vol. 22 (2011) pp. 94–102; doi: 10.1016/j.yebeh.2011.02.009
[PDF]
[DOI]
Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy
D.S. Reddy. Frontiers in Endocrinology Vol. 2 p. 38 (2011); doi: 10.3389/fendo.2011.00038
[PDF]
[DOI]
Neurosteroids: Endogenous Role in the Human Brain and Therapeutic Potentials
D.S. Reddy. Progress in Brain Research Vol. 186 (2010) pp. 113–137
[PDF]
Neurosteroids: Potential for Use in Treating Catamenial Epilepsy
D.S. Reddy. Epilepsy Currents Vol. 10(5) pp. 121–122 (2010)
Special Issue: Sex Differences in Epilepsy
D.S. Reddy. Epilepsy & Behavior Special Issue Introduction; 2010
[PDF]
The Testosterone-Derived Neurosteroid Androstanediol Is a Positive Allosteric Modulator of GABAA Receptors
D.S. Reddy, Kuihuan Jian. Journal of Pharmacology and Experimental Therapeutics Vol. 334 pp. 1031–1041 (2010)
[PDF]
[DOI]
Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis
D.S. Reddy, Omkaram Gangisetty, Seema Briyal. Neuropharmacology Vol. 59 pp. 573–581 (2010)
[PDF]
[DOI]
NEUROSTEROID WITHDRAWAL REGULATES GABA-A RECEPTOR 4-SUBUNIT EXPRESSION AND SEIZURE SUSCEPTIBILITY BY ACTIVATION OF PROGESTERONE RECEPTOR-INDEPENDENT EARLY GROWTH RESPONSE FACTOR-3 PATHWAY
Omkaram Gangisetty, D.S. Reddy. Neuroscience Vol. 170 pp. 865–880 (2010)
[PDF]
[DOI]
Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives
D.S. Reddy. Expert Review of Clinical Pharmacology Vol. 3(2) pp. 183–192 (2010); doi: 10.1586/ECP.10.3
[PDF]
[DOI]
Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy
D.S. Reddy, Michael A. Rogawski. Epilepsia Vol. 51 Suppl. 5 p. 84 (2010); doi: 10.1111/j.1528-1167.2010.02870.x
[PDF]
[DOI]
Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model
D.S. Reddy, Michael A. Rogawski. Epilepsy Research Vol. 89 (2010) pp. 254–260; doi: 10.1016/j.eplepsyres.2010.01.009
[PDF]
[DOI]
Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model
D.S. Reddy, Michael A. Rogawski. Epilepsy Research Vol. 89, pp. 254–260; Received 14 September 2009; Revised 5 January 2010; Accepted 16 January 2010; Available online 20 February 2010
[PDF]
[DOI]
Funding Opportunities in Biomedical Sciences and Preparing a Successful Grant Application
C. Adithan, D.S. Reddy. Funding Opportunities in Biomedical Sciences Chapter 34, SECTION H Seeking Research Support
[PDF]
Steroid Hormones and Sex Differences in Seizure Susceptibility
D.S. Reddy. Encyclopedia of Basic Epilepsy Research Vol 1.
Oxford: Academic Press; 2009. pp. 526-533.
[PDF]
[DOI]
Neurosteroid Replacement Therapy for Catamenial Epilepsy
D.S. Reddy, M.A. Rogawski. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics Vol. 6 pp. 392–401 (2009); doi: 10.1016/j.nurt.2009.01.015
[PDF]
[DOI]
The optimization of TaqMan real-time RT-PCR assay for transcriptional profiling of GABA-A receptor subunit plasticity
Omkaram Gangisetty, D.S. Reddy. Journal of Neuroscience Methods Vol. 181 pp. 58–66 (2009)
[PDF]
[DOI]
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
D.S. Reddy. Epilepsy Research Vol. 85 (2009) pp. 1–30; doi: 10.1016/j.eplepsyres.2009.02.017
[PDF]
[DOI]
Oral Contraceptive Use Among Women with Epilepsy
D.S. Reddy. Epilepsia Vol. 49 Suppl. pp. 106–107 (2008)
[PDF]
Mass spectrometric assay and physiological–pharmacological activity of androgenic neurosteroids
D.S. Reddy. Neurochemistry International Vol. 52 pp. 541–553 (2008)
[PDF]
[DOI]
Recent Advances in Hormonal Contraceptives for Women
D.S. Reddy. International Journal of Pharmaceutical Sciences and Nanotechnology Vol. 1 Issue 3 (2008)
[PDF]
[DOI]
Differential Anesthetic Activity of Ketamine and the GABAergic Neurosteroid Allopregnanolone in Mice Lacking Progesterone Receptor A and B subtypes
D.S. Reddy and Y.-C. Zeng. Methods and Findings in Experimental and Clinical Pharmacology Vol. 29(10) pp. 659–664 (2007)
[PDF]
[DOI]
Perimenstrual catamenial epilepsy
D.S. Reddy. Women's Health Vol. 3(2) pp. 195–206 (2007); doi: 10.2217/17455057.3.2.195
[PDF]
[DOI]
PHYSIOLOGICAL ROLE OF ADRENAL DEOXYCORTICOSTERONE-DERIVED NEUROACTIVE STEROIDS IN STRESS-SENSITIVE CONDITIONS
D.S. Reddy. Neuroscience Vol. 138 pp. 911–920 (2006)
[PDF]
[DOI]
Patch-clamp recording and analysis of GABA-gated chloride currents in acutely dissociated hippocampal neurons from adult mice
D.S. Reddy, Hugh Criswell. Frontiers in Neuroendocrinology (ICN 2006 Conference Abstracts) Vol. 27 (2006) pp. 111–117; doi: 10.1016/j.yfrne.2006.03.289
[PDF]
[DOI]
Protective effects of GABAergic neurosteroids in a rat model of chronic temporal lobe epilepsy
Y.-C. Zeng, A.K. Shetty, D.S. Reddy. Frontiers in Neuroendocrinology (ICN 2006 Conference Abstracts) Vol. 27 (2006); doi: 10.1016/j.yfrne.2006.03.293
[PDF]
[DOI]
Hippocampal Neurodegeneration, Spontaneous Seizures, and Mossy Fiber Sprouting in the F344 Rat Model of Temporal Lobe Epilepsy
Muddanna S. Rao, Bharathi Hattiangady, D.S. Reddy, Ashok K. Shetty. Journal of Neuroscience Research Vol. 83 (2006) pp. 1088–1105; doi: 10.1002/jnr.20802
[PDF]
[DOI]
Hippocampal Neurodegeneration, Spontaneous Seizures, and Mossy Fiber Sprouting in the F344 Rat Model of Temporal Lobe Epilepsy
Muddanna S. Rao, Bharathi Hattiangady, D.S. Reddy, Ashok K. Shetty. Journal of Neuroscience Research Vol. 83, pp. 1088–1105; Received 4 October 2005; Revised 2 January 2006; Accepted 3 January 2006; Published online 21 February 2006
[PDF]
[DOI]
Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice
D.S. Reddy, Leigh Ann Apanites. Brain Research Vol. 1033 (2005) pp. 96–101; Accepted 19 Nov 2004; Available online 8 Jan 2005
[PDF]
[DOI]
Pharmacotherapy of catamenial epilepsy
D.S. Reddy. Indian Journal of Pharmacology Indian Journal of Pharmacology 37(5):p 288-293
[PDF]
[DOI]
Anxiolytic activity of progesterone in progesterone receptor knockout mice
D.S. Reddy, B.W. O'Malley, M.A. Rogawski. Neuropharmacology Vol. 48 pp. 14–24 (2005)
[PDF]
[DOI]
A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol in plasma
D.S. Reddy, Lata Venkatarangan, Benjamin Chien, Kumar Ramu. Steroids Vol. 70 pp. 879–885 (2005); doi: 10.1016/j.steroids.2005.05.007
[PDF]
[DOI]
Role of neurosteroids in catamenial epilepsy
D.S. Reddy. Epilepsy Research Vol. 62 (2004) pp. 99–118; Received 19 Feb 2004; Accepted 20 Sep 2004
[PDF]
[DOI]
Pharmacology of Catamenial Epilepsy
D.S. Reddy. Methods and Findings in Experimental and Clinical Pharmacology Vol. 26(7) pp. 547–561 (2004); © 2004 Prous Science
[PDF]
[DOI]
Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice
D. S. Reddy, D. C. Castaneda, B. W. O’Malley, and M. A. Rogawski. Journal of Pharmacology and Experimental Therapeutics Vol. 310 pp. 230–239 (2004)
[PDF]
[DOI]
Anticonvulsant activity of the testosterone-derived neurosteroid 3a-androstanediol
D.S. Reddy. NeuroReport Vol. 15 pp. 515–518 (2004)
[PDF]
[DOI]
TESTOSTERONE MODULATION OF SEIZURE SUSCEPTIBILITY IS MEDIATED BY NEUROSTEROIDS 3-ANDROSTANEDIOL AND 17-ESTRADIOL
D.S. Reddy. Neuroscience Vol. 129 pp. 195–207 (2004)
[PDF]
[DOI]
Ganaxolone: a prospective overview
D.S. Reddy, Richard Woodward. Drugs of the Future Vol. 29(3) pp. 227–242 (2004)
[PDF]
[DOI]
Ganaxolone: a prospective overview
D.S. Reddy, Richard Woodward. Drugs of the Future Vol. 29, No. 3, pp. 227–242
[PDF]
[DOI]
Pharmacology of Endogenous Neuroactive Steroids
D.S. Reddy. Critical Reviews in Neurobiology Vol. 15(3&4) pp. 197–234 (2003); © 2003 Begell House, Inc.
[PDF]
[DOI]
Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?
D.S. Reddy. Trends in Pharmacological Sciences Vol. 24(3) pp. 103–106 (2003)
[PDF]
[DOI]
The Clinical Potentials of Endogenous Neurosteroids
D.S. Reddy. Drugs of Today Vol. 38(7) pp. 465–485 (2002); © 2002 Prous Science
[PDF]
[DOI]
Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABAA Receptor Function and Seizure Susceptibility
D.S. Reddy, M.A. Rogawski. Journal of Neuroscience Vol. 22(9) pp. 3795–3805 (2002)
[PDF]
[DOI]
Neurosteroid Withdrawal Model of Perimenstrual Catamenial Epilepsy
Doodipala S. Reddy,Hee-Yong Kim, and Michael A. Rogawski. Epilepsia Vol.42(3):328–336,
[PDF]
[DOI]
Neurosteroid Withdrawal Model of Perimenstrual Catamenial Epilepsy
D.S. Reddy, Hee-Yong Kim, Michael A. Rogawski. Epilepsia Vol. 42(3) pp. 328–336 (2001)
[PDF]
[DOI]
Enhanced Anticonvulsant Activity of Neuroactive Steroids in a Rat Model of Catamenial Epilepsy
D.S. Reddy, Michael A. Rogawski. Epilepsia Vol. 42(3) pp. 337–344 (2001)
[PDF]
[DOI]
Enhanced Anticonvulsant Activity of Ganaxolone after Neurosteroid Withdrawal in a Rat Model of Catamenial Epilepsy
D.S. Reddy, M.A. Rogawski. Journal of Pharmacology and Experimental Therapeutics Vol. 294 pp. 909–915 (2000)
[PDF]
[DOI]
Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself
D.S. Reddy, M.A. Rogawski. Journal of Pharmacology and Experimental Therapeutics Vol. 295 pp. 1241–1248 (2000)
[PDF]
[DOI]
Nitric oxide and neurosteroid modulation of benzodiazepine withdrawal-induced seizures in mice
D.S. Reddy, S.K. Kulkarni. Pharmacology Biochemistry and Behavior Vol. 62 pp. 53–60 (1999)
[PDF]
The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice
D.S. Reddy, S.K. Kulkarni. Brain Research Vol. 791 (1998) pp. 108–116; Accepted 20 Jan 1998
[PDF]
[DOI]
Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment
D.S. Reddy, Shrinivas K. Kulkarni. Brain Research Vol. 799 (1998) pp. 215–229; Accepted 14 Apr 1998
[PDF]
[DOI]
Sigma (s1) receptor mediated anti- depressant-like effects of neurosteroids in the Porsolt forced swim test
Doodipala Samba Reddy,
Gurpreet Kaur
and Shrinivas K. Kulkarni. NeuroReport Vol. 9 pp. 3069–3073 (1998)
[PDF]
[DOI]
The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice
D.S. Reddy, S.K. Kulkarni. Psychopharmacology Vol. 137 pp. 391–400 (1998)
[PDF]
[DOI]
Tiagabine: A potent antiepileptic drug with selective GABA uptake inhibitory effect
D.S. Reddy. Indian Journal of Pharmacology Vol. 30 pp. 141–151 (1998); Educational Forum
[PDF]
Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice
D.S. Reddy, Shrinivas K. Kulkarni. European Journal of Pharmacology Vol. 345 (1998) pp. 55–59
[PDF]
[DOI]
Potential Mechanisms of Neurosteroid-Induced Attenuation of Morphine Tolerance and Dependence
D.S. Reddy, S.K. Kulkarni. Indian Journal of Pharmacology Vol. 30 (1998) pp. 6–15
[PDF]
[DOI]
Pharmacotherapy of Male Erectile Dysfunction with Sildenafil
S.K. Kulkarni, D.S. Reddy. Indian Journal of Pharmacology Vol. 30 (1998) pp. 367–378
[PDF]
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice
D.S. Reddy, S.K. Kulkarni. Brain Research Vol. 752 (1997) pp. 61–71; Accepted 26 Nov 1996
[PDF]
[DOI]
Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice
D.S. Reddy, Shrinivas K. Kulkarni. European Journal of Pharmacology Vol. 337 (1997) pp. 19–25
[PDF]
[DOI]
Assessment of Nootropic and Amnestic Activity of Centrally Acting Agents
D.S. Reddy. Indian Journal of Pharmacology Vol. 29 (1997) pp. 208–221
[PDF]
Neuroprotective Effects of Neurosteroids Against Hypoxic-Neurotoxicity in Naive and Benzodiazepine Inverse Agonist FG 7142-Treated Mice
D.S. Reddy, S.K. Kulkarni. Indian Journal of Pharmacology Vol. 29 (1997) pp. 381–392
[PDF]
Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice
D.S. Reddy, S.K. Kulkarni. Psychopharmacology Vol. 128 pp. 280–292 (1996)
[PDF]
[DOI]
Signalling Mechanisms of Cardiac Hypertrophy
D.S. Reddy, M. Singh, K. Chopra. Indian Journal of Pharmacology Vol. 28 (1996) pp. 58–71
[PDF]